1A7X | A:1-107; B:1-107 | FKBP12-FK1012 COMPLEX |
1B6C | A:1-107; C:1-107; E:1-107; G:1-107 | CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF THE TYPE I TGF-BETA RECEPTOR IN COMPLEX WITH FKBP12 |
1BKF | A:1-107 | FK506 BINDING PROTEIN FKBP MUTANT R42K/H87V COMPLEX WITH IMMUNOSUPPRESSANT FK506 |
1BL4 | A:1-107; B:1-107 | FKBP MUTANT F36V COMPLEXED WITH REMODELED SYNTHETIC LIGAND |
1C9H | A:1-107 | CRYSTAL STRUCTURE OF FKBP12.6 IN COMPLEX WITH RAPAMYCIN |
1D6O | A:1-107; B:1-107 | NATIVE FKBP |
1D7H | A:1-107; B:1-107 | FKBP COMPLEXED WITH DMSO |
1D7I | A:1-107; B:1-107 | FKBP COMPLEXED WITH METHYL METHYLSULFINYLMETHYL SULFIDE (DSS) |
1D7J | A:1-107; B:1-107 | FKBP COMPLEXED WITH 4-HYDROXY-2-BUTANONE |
1EQ3 | A:36-131 | NMR STRUCTURE OF HUMAN PARVULIN HPAR14 |
1EYM | A:1-107; B:1-107 | FK506 BINDING PROTEIN MUTANT, HOMODIMERIC COMPLEX |
1F40 | A:1-107 | SOLUTION STRUCTURE OF FKBP12 COMPLEXED WITH GPI-1046, A NEUROTROPHIC LIGAND |
1F8A | B:58-167 | STRUCTURAL BASIS FOR THE PHOSPHOSERINE-PROLINE RECOGNITION BY GROUP IV WW DOMAINS |
1FAP | A:1-107 | THE STRUCTURE OF THE IMMUNOPHILIN-IMMUNOSUPPRESSANT FKBP12-RAPAMYCIN COMPLEX INTERACTING WITH HUMAN FRAP |
1FJD | A:28-131 | HUMAN PARVULIN-LIKE PEPTIDYL PROLYL CIS/TRANS ISOMERASE, HPAR14 |
1FKB | A:1-107 | ATOMIC STRUCTURE OF THE RAPAMYCIN HUMAN IMMUNOPHILIN FKBP-12 COMPLEX |
1FKD | A:1-107 | FK-506 BINDING PROTEIN: THREE-DIMENSIONAL STRUCTURE OF THE COMPLEX WITH THE ANTAGONIST L-685,818 |
1FKF | A:1-107 | ATOMIC STRUCTURE OF FKBP-FK506, AN IMMUNOPHILIN-IMMUNOSUPPRESSANT COMPLEX |
1FKG | A:1-107 | DESIGN, SYNTHESIS, AND KINETIC EVALUATION OF HIGH-AFFINITY FKBP LIGANDS, AND THE X-RAY CRYSTAL STRUCTURES OF THEIR COMPLEXES WITH FKBP12 |
1FKH | A:1-107 | DESIGN, SYNTHESIS, AND KINETIC EVALUATION OF HIGH-AFFINITY FKBP LIGANDS, AND THE X-RAY CRYSTAL STRUCTURES OF THEIR COMPLEXES WITH FKBP12 |
1FKI | A:1-107; B:1-107 | DESIGN, SYNTHESIS, AND KINETIC EVALUATION OF HIGH-AFFINITY FKBP LIGANDS, AND THE X-RAY CRYSTAL STRUCTURES OF THEIR COMPLEXES WITH FKBP12 |
1FKJ | A:1-107 | ATOMIC STRUCTURE OF FKBP12-FK506, AN IMMUNOPHILIN IMMUNOSUPPRESSANT COMPLEX |
1FKR | A:1-107 | SOLUTION STRUCTURE OF FKBP, A ROTAMASE ENZYME AND RECEPTOR FOR FK506 AND RAPAMYCIN |
1FKS | A:1-107 | SOLUTION STRUCTURE OF FKBP, A ROTAMASE ENZYME AND RECEPTOR FOR FK506 AND RAPAMYCIN |
1FKT | A:1-107 | SOLUTION STRUCTURE OF FKBP, A ROTAMASE ENZYME AND RECEPTOR FOR FK506 AND RAPAMYCIN |
1J4H | A:1-107 | CRYSTAL STRUCTURE ANALYSIS OF THE FKBP12 COMPLEXED WITH 000107 SMALL MOLECULE |
1J4I | A:1-107 | CRYSTAL STRUCTURE ANALYSIS OF THE FKBP12 COMPLEXED WITH 000308 SMALL MOLECULE |
1J4R | A:1-107; B:1-107; D:1-107 | FK506 BINDING PROTEIN COMPLEXED WITH FKB-001 |
1KT0 | A:34-139; A:140-253 | STRUCTURE OF THE LARGE FKBP-LIKE PROTEIN, FKBP51, INVOLVED IN STEROID RECEPTOR COMPLEXES |
1N1A | A:16-140; B:16-140 | CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF HUMAN FKBP52 |
1NMV | A:52-163 | SOLUTION STRUCTURE OF HUMAN PIN1 |
1NMW | A:50-163 | SOLUTION STRUCTURE OF THE PPIASE DOMAIN OF HUMAN PIN1 |
1NSG | A:1-107 | THE STRUCTURE OF THE IMMUNOPHILIN-IMMUNOSUPPRESSANT FKBP12-RAPAMYCIN COMPLEX INTERACTING WITH HUMAN FRAP |
1P5Q | A:145-260; B:145-260; C:145-260 | CRYSTAL STRUCTURE OF FKBP52 C-TERMINAL DOMAIN |
1PBK | A:109-224 | HOMOLOGOUS DOMAIN OF HUMAN FKBP25 |
1PIN | A:54-163 | PIN1 PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FROM HOMO SAPIENS |
1Q1C | A:21-139; A:140-257 | CRYSTAL STRUCTURE OF N(1-260) OF HUMAN FKBP52 |
1QPF | A:1-107; D:201-307 | FK506 BINDING PROTEIN (12 KDA, HUMAN) COMPLEX WITH L-709,858 |
1QPL | A:1-107; C:201-307 | FK506 BINDING PROTEIN (12 KDA, HUMAN) COMPLEX WITH L-707,587 |
1QZ2 | A:1-261; B:1-261; C:1-261 | CRYSTAL STRUCTURE OF FKBP52 C-TERMINAL DOMAIN COMPLEX WITH THE C-TERMINAL PEPTIDE MEEVD OF HSP90 |
1ZCN | A:51-163 | HUMAN PIN1 NG MUTANT |
2DG3 | A:1-107 | WILDTYPE FK506-BINDING PROTEIN COMPLEXED WITH RAPAMYCIN |
2DG4 | A:1-107 | FK506-BINDING PROTEIN MUTANT WF59 COMPLEXED WITH RAPAMYCIN |
2DG9 | A:1-107 | FK506-BINDING PROTEIN MUTANT WL59 COMPLEXED WITH RAPAMYCIN |
2F21 | A:50-163 | HUMAN PIN1 FIP MUTANT |
2FAP | A:1-107 | THE STRUCTURE OF THE IMMUNOPHILIN-IMMUNOSUPPRESSANT FKBP12-(C16)-ETHOXY RAPAMYCIN COMPLEX INTERACTING WITH HUMA |
2FKE | A:1-107 | FK-506-BINDING PROTEIN: THREE-DIMENSIONAL STRUCTURE OF THE COMPLEX WITH THE ANTAGONIST L-685,818 |
2ITK | A:54-163 | HUMAN PIN1 BOUND TO D-PEPTIDE |
2Q5A | A:54-163 | HUMAN PIN1 BOUND TO L-PEPTIDE |
2ZQS | A:54-163 | CRYSTAL STRUCTURE OF A MUTANT PIN1 PEPTIDYL-PROLYL CIS-TRANS ISOMERASE |
2ZQT | A:54-163 | CRYSTAL STRUCTURE OF A MUTANT PIN1 PEPTIDYL-PROLYL CIS-TRANS ISOMERASE |
2ZQU | A:54-163 | CRYSTAL STRUCTURE OF A MUTANT PIN1 PEPTIDYL-PROLYL CIS-TRANS ISOMERASE |
2ZQV | A:54-163 | CRYSTAL STRUCTURE OF A MUTANT PIN1 PEPTIDYL-PROLYL CIS-TRANS ISOMERASE |
2ZR4 | A:54-163 | CRYSTAL STRUCTURE OF A MUTANT PIN1 PEPTIDYL-PROLYL CIS-TRANS ISOMERASE |
2ZR5 | A:54-163 | CRYSTAL STRUCTURE OF A MUTANT PIN1 PEPTIDYL-PROLYL CIS-TRANS ISOMERASE |
2ZR6 | A:54-163 | CRYSTAL STRUCTURE OF A MUTANT PIN1 PEPTIDYL-PROLYL CIS-TRANS ISOMERASE |
3B7X | A:19-143 | CRYSTAL STRUCTURE OF HUMAN FK506-BINDING PROTEIN 6 |
3FAP | A:1-107 | ATOMIC STRUCTURES OF THE RAPAMYCIN ANALOGS IN COMPLEX WITH BOTH HUMAN FKBP12 AND FRB DOMAIN OF FRAP |
3I6C | A:51-163; B:51-163 | STRUCTURE-BASED DESIGN OF NOVEL PIN1 INHIBITORS (II) |
3IK8 | B:54-163; A:51-163 | STRUCTURE-BASED DESIGN OF NOVEL PIN1 INHIBITORS (I) |
3IKD | B:54-163; A:51-163 | STRUCTURE-BASED DESIGN OF NOVEL PIN1 INHIBITORS (I) |
3IKG | A:51-163; B:51-163 | STRUCTURE-BASED DESIGN OF NOVEL PIN1 INHIBITORS (I) |
3JYJ | A:51-163; B:51-163 | STRUCTURE-BASED DESIGN OF NOVEL PIN1 INHIBITORS (II) |
3KAB | A:54-163 | STRUCTURE-GUIDED DESIGN OF ALPHA-AMINO ACID-DERIVED PIN1 INHIBITORS |
3KAC | A:51-163; B:49-163 | STRUCTURE-GUIDED DESIGN OF ALPHA-AMINO ACID-DERIVED PIN1 INHIBITORS |
3KAD | A:54-163 | STRUCTURE-GUIDED DESIGN OF ALPHA-AMINO ACID-DERIVED PIN1 INHIBITORS |
3KAF | A:54-163 | STRUCTURE-GUIDED DESIGN OF ALPHA-AMINO ACID-DERIVED PIN1 INHIBITORS |
3KAG | A:54-163 | STRUCTURE-GUIDED DESIGN OF ALPHA-AMINO ACID-DERIVED PIN1 INHIBITORS |
3KAH | A:54-163 | STRUCTURE-GUIDED DESIGN OF ALPHA-AMINO ACID-DERIVED PIN1 INHIBITORS |
3KAI | A:54-163 | STRUCTURE-GUIDED DESIGN OF ALPHA-AMINO ACID-DERIVED PIN1 INHIBITORS |
3KCE | A:54-163 | STRUCTURE-GUIDED DESIGN OF ALPHA-AMINO ACID-DERIVED PIN1 INHIBITORS |
4FAP | A:1-107 | ATOMIC STRUCTURES OF THE RAPAMYCIN ANALOGS IN COMPLEX WITH BOTH HUMAN FKBP12 AND FRB DOMAIN OF FRAP |